Complications of the COVID-19 in a hypertensive patient
Keywords:
COVID-19, pulmonary distress, pulmonary embolism, arterial hypertension, intensive care unit.Abstract
Introduction: The rapid expansion of COVID-19 caused the World Health Organization, on January 30, 2020, to declare it a health emergency and recognized it as a pandemic on March 11 of the same year.Objective: To describe the clinical evolution of a hypertensive patient, affected by COVID-19.
Clinical case: This is a 49-year-old patient, hypertensive, affected by COVID-19, treated at the Dr. "Joaquín Castillo Duany" Military Hospital, who during his stay in the intensive care unit, suffered serious complications such as: acute respiratory distress syndrome, pneumonia associated with mechanical artificial ventilation, and pulmonary thromboembolism. The delay in going to the hospital, arterial hypertension, and previous treatment with angiotensin-converting enzyme inhibitors, were among the variables present in this patient, which possibly had a negative impact on his evolution.
Conclusion: With intensive treatment, the ventilatory and anticoagulation strategy used, evolved favorably until his hospital discharge.
Downloads
References
2. Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020 [acceso:23/05/2020];323(8):707-8. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815
3. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020[acceso:23/05/2020];58(7):1-10 . Disponible en: https://doi.org/10.1515/cclm-2020-0198
4. Acosta G , Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterización de pacientes con Covid-19 grave atendidos en un hospital de referencia nacional del Perú. Rev Peru Med Exp Salud Pública. 2020 [acceso: 05/06/2020];37(4):1-6. DOI: 10.17843.2020.372.5437
5. Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev haban cienc méd. 2020[acceso: 04/06/2020];19(2):e_3254. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254/2505
6. Guan W, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb [acceso:29/05/2020]28;1-13. DOI:10.1056/2002032
7. Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute síndrome coronavirus 2 infection. J Am Heart Assoc. 2020 Apr 07 [acceso:19/05/2020];9(7):e016219. Disponible en: https://www.ahajournals.org/doi/epub/10.1161/JAHA.120.016219
8. Loan AM, Durante López A, Martínez Milla J, Pérez Calvo C, Santos A. Tromboembolia pulmonar en la COVID-19: Cuando nada es lo que parece. Rev Esp Cardiol. [acceso: 05/06/2020]. DOI:10.1016.2020.04.013
9. Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020[acceso:05/06/2020];20:124-7. DOI: 10.7861.2019
10. Chen N, Zhou M, Dong X, Qu J, Gong R, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020[acceso:09/06/2020];39(10223):507-13. Disponible en: https://www.thelancet.com/pdfs/journals/lancet/PIISO140-6736(20)30211-7.pdf
11. Noya Chaveco ME, Moya González NL. Roca Goderich. Temas de Medicina Interna. 5 ed. La Habana: Editorial Ciencias Médicas; 2017. p.478-95. Tomo 1.
12. Xie Y, Wang X, Yang P, Zhang S. COVID-19 complicated by acute pulmonary embolism. Radiol Cardiothorac Imaging. 2020[acceso:09/06/2020];2(2):e200067. DOI: 10.1148/ryct.2020200067
Published
How to Cite
Issue
Section
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.